Case report: Hepatitis A preceding Guillain-Barré syndrome

Journal of Medical Virology

Volumn 78, Issue 8, 2006, Pages 1011-1014

  Chitambar, Shobha D ^a   Fadnis, Rahul S ^a   Joshi, Madhuri S ^a   Habbu, A ^b   Bhatia, S G ^b  

^a NATIONAL INSTITUTE OF VIROLOGY   (India)

^b Sassoon General Hospital   (India)

Author keywords

Anti HAV antibodies; Guillain Barr Syndrome; Hepatitis A virus

Indexed keywords

ANTIBIOTIC AGENT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CASE REPORT; DISEASE CLASSIFICATION; DISEASE COURSE; FECES ANALYSIS; GUILLAIN BARRE SYNDROME; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INDIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PROTEIN CEREBROSPINAL FLUID LEVEL; VIRUS GENOME;

ADOLESCENT; GUILLAIN-BARRE SYNDROME; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A VIRUS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; RNA, VIRAL; TIME FACTORS;

HEPATITIS A VIRUS;

EID: 33745713021     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20656     Document Type: Article

References (27)

1. Adams RD, Asbury AK. 1980. Diseases of peripheral nervous system. In: Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, editors. Harrisons principles of internal medicine. New York: MacGraw Hill. pp 2097-3030.
2. Ang CW, Jacobs BC, Brandenburg AH, Laman JD, Van der Meche FG, Osterhaus AD, VanDoorn PA. 2000. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barre syndrome. Neurology 54:1453-1458.
3. Arankalle VA, Chadha MS, Tsarev SA, Emerson SU, Risbud AR, Banerjee K, Purcell RH. 1994. Seroepidemiology of water borne Hepatitis in India and evidence for a third enterically transmitted Hepatitis agent. Proc Natl Acad Sci USA 91:3428-3432.
4. Bosch VV, Bowling PC, Cook SD. 1983. Hepatitis A virus immunoglbulin M antibody in acute neurological disease. Ann Neurol 14:685-687.
5. Bower WA, Nainan OV, Han X, Margolis HS. 2000. Duration of viremia in hepatitis A virus infection. J Infect Dis 187:12-17.
6. Chitambar SD, Grewal SM, Bokil M, Arankalle VA, Gore MM, Banerjee K. 1994. Indigenous anti-hepatitis A virus IgM capture ELISA for the diagnosis of hepatitis A. Indian J Med Res 99:243-251.
7. Chitambar SD, Joshi MS, Sreenivasan MA, Arankalle VA. 2001. Fecal shedding of hepatitis A virus in Indian patients with hepatitis A in experimentally infected Rhesus monkey. Hepatol Res 19:237-246.
8. Endoh J, Ogasawara N, Mushimoto M. 1991. Guillain-Barre syndrome following acute hepatitis A. Rinsho Shinkeigaku 31:210-212.
9. Glikson M, Galun E, Oren R, Tur-Kaspa R, Shouval D. 1992. Relapsing hepatitis A: Review of 14 cases and literature survey. Medicine 71:14-23.
10. Hadden RD, KarchH, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV. 2001. Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758-765.
11. Hughes RA, Hadden RD, Gregson NA, Smith KJ. 1999. Pathogenesis of Guillain Barre syndrome. J Neuroimmunol 100:74-97.
12. Igarashi M, Tomono M, Uchida S, Yamashiro Y, Namihisa T, Tana S. 1983. Guillain-Barre syndrome associated with acute hepatitis A. Gastroenterol Jpn 18:549-552.
13. Inoue K, Yoshiba M, Yotsuyanagi H, Otsuka T, Sekiyama K, Fujita R. 1996. Chronic Hepatitis A with persistent viral replication. J Med Virol 50:322-324.
14. Joshi MS, Chitambar SD, Arankalle VA, Chadha MS. 2002. Evaluation of urine as a clinical specimen for diagnosis of Hepatitis A. J Clin Diagn Lab Immunol 9:840-845.
15. Kocabas E, Yildizdas D. 2004. A child with Guillain-Barre syndrome caused by acute hepatitis A infection. Indian Pediatr 41:92-93.
16. McDonald GSA, Courtney MG, Shattock AG, Weir DG. 1989. Prolonged IgM antibodies and histopathological evidence of chronicity in hepatitis A. Liver 9:223-228.
17. Owen RI, Dau PC, Johnson KP, Spitler LE. 1980. Immunologic mechanisms in multiple sclerosis: Exacerbation by type A hepatitis and skin test antigens. J Am Med Assoc 244:2307-2309.
18. Pelletier G, Elghozi D, Trepo C, Layerdant C, Benhamou J. 1985. Mononeuritis in acute viral hepatitis. Digestion 32:53-56.
19. Robertson BH, Janes RW, Khanna B, Totsuko A, Nainan OV, Siegl G, Widell A. 1992. Genetic relatedness of hepatitis A virus strains recovered from different geographical regions. J Gen Virol 73:1365-1377.
20. Sata M, Nakano H, Tanaka E, Kumashiro R, Suzuki H, Tanikawa K. 1996. Analysis of serum hepatitis A virus antibody response in different courses of hepatitis A virus infection. J Gastroenterol 31:812-817.
21. Saunders SJ, Seggie J, Kirsch RE, Terblanche J. 1979. Acute liver failure. In: Wright R, Alberti KGMM, Karran S, Millward-Sadler GH, editors. Liver and biliary disease. Philadelphia: WB Saunders. pp 569-584.
22. Schiff L. 1992. Atypical clinical manifestations of hepatitis A. Vaccine 10:S18-S20.
23. Shimoya K, Ohnishi A, Hashimoto T, Yuki N. 1997. Guillain-Barre syndrome with high titers of anti-GM2 and anti-GalNAc-GD1a antibody following cytomegalovirus hepatitis. Rinsho Shinkeigaku 37:106-110.
24. Steininger C, Popow-Kraupp T, Seiser A, Gueler N, Stanek G, Puchhammer E. 2004. Presence of cytomegalovirus in cerebrospinal fluid of patients with Guillain Barre syndrome. J Infect Dis 189:984-989.
25. Tandon R, Garg MC, Bajpai HS, Agrawal JK. 1986. Guillain-Barre syndrome following acute infective hepatitis. JAPI 34:444-445.
26. Yotsuyanagi H, Koike K, Yasuda K, Moriya K, Shintani Y, Fujie H, Furokawa K, Iino S. 1996. Prolonged fecal excretion of Hepatitis A virus in adult patients with Hepatitis A as determined by polymerase chain reaction. Hepatology 24:10-13.
27. Yuki N. 2001. Infectious origin of, and molecular mimicry in, Guillain Barre and Fishersyndromes. Lancet Infect Dis 1:29-37.